Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 1772 for

Edit search filters
  1. A Study Of Enfortumab Vedotin Alone Or With Other Therapies For Treatment Of Urothelial Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  2. SX-682 Treatment In Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab

    Rochester, MN

  3. A Study Of CART-TnMUC1 In Patients With TnMUC1-Positive Advanced Cancers

    Scottsdale/Phoenix, AZ

  4. A Study To Evaluate Gilteritinib Vs. Midostaurin In FLT3 Mutated Acute Myeloid Leukemia

    Jacksonville, FL, Rochester, MN

  5. INHERIT Study To Evaluate Proactive Genetic Testing In Cancer Patients

    Jacksonville, FL

  6. Phase 3 Trial Of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment Of Advanced Renal Cell Carcinoma (RCC)

    Scottsdale/Phoenix, AZ

  7. Study Of Biomarker-Based Treatment Of Acute Myeloid Leukemia

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Dose-Escalation Study Of Cevostamab (BFCR4350A) In Participants With Relapsed Or Refractory Multiple Myeloma (R/R MM)

    Scottsdale/Phoenix, AZ

  9. A Study Of Atezolizumab As Adjuvant Therapy In Participants With Renal Cell Carcinoma (RCC) At High Risk Of Developing Metastasis Following Nephrectomy

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. Dendritic Cell Therapy After Cryosurgery In Combination With Pembrolizumab In Treating Patients With Stage III-IV Melanoma That Cannot Be Remove By Surgery

    Rochester, MN

.

Mayo Clinic Footer